Henry Schein, Inc. $HSIC Shares Acquired by TD Asset Management Inc

TD Asset Management Inc increased its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 0.8% in the 2nd quarter, HoldingsChannel reports. The institutional investor owned 22,016 shares of the company’s stock after buying an additional 164 shares during the period. TD Asset Management Inc’s holdings in Henry Schein were worth $1,608,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also modified their holdings of HSIC. GAMMA Investing LLC boosted its holdings in shares of Henry Schein by 37.8% in the 1st quarter. GAMMA Investing LLC now owns 3,939 shares of the company’s stock valued at $270,000 after buying an additional 1,081 shares during the period. Wealth Enhancement Advisory Services LLC boosted its holdings in shares of Henry Schein by 0.5% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 53,134 shares of the company’s stock valued at $3,639,000 after buying an additional 243 shares during the period. State of Alaska Department of Revenue boosted its holdings in shares of Henry Schein by 2.8% in the 1st quarter. State of Alaska Department of Revenue now owns 14,611 shares of the company’s stock valued at $1,000,000 after buying an additional 395 shares during the period. Oppenheimer Asset Management Inc. boosted its holdings in shares of Henry Schein by 5.2% in the 1st quarter. Oppenheimer Asset Management Inc. now owns 13,745 shares of the company’s stock valued at $941,000 after buying an additional 678 shares during the period. Finally, Moran Wealth Management LLC acquired a new position in shares of Henry Schein in the 1st quarter valued at about $3,977,000. 96.62% of the stock is owned by institutional investors and hedge funds.

Henry Schein Stock Down 1.1%

HSIC stock opened at $63.51 on Thursday. Henry Schein, Inc. has a 52 week low of $60.56 and a 52 week high of $82.49. The company has a market capitalization of $7.70 billion, a price-to-earnings ratio of 20.49, a price-to-earnings-growth ratio of 2.12 and a beta of 0.81. The firm’s 50-day moving average is $66.90 and its two-hundred day moving average is $68.53. The company has a current ratio of 1.41, a quick ratio of 0.78 and a debt-to-equity ratio of 0.51.

Henry Schein (NASDAQ:HSIC) last released its earnings results on Tuesday, August 5th. The company reported $1.10 EPS for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.09). Henry Schein had a return on equity of 14.36% and a net margin of 3.05%.The business had revenue of $3.24 billion during the quarter, compared to the consensus estimate of $3.22 billion. During the same quarter in the previous year, the firm earned $1.23 earnings per share. The firm’s revenue for the quarter was up 3.3% compared to the same quarter last year. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. On average, analysts forecast that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research firms have issued reports on HSIC. Weiss Ratings reissued a “hold (c)” rating on shares of Henry Schein in a research note on Wednesday, October 8th. UBS Group reduced their target price on shares of Henry Schein from $75.00 to $70.00 and set a “neutral” rating for the company in a research note on Wednesday, August 6th. Baird R W lowered shares of Henry Schein from a “strong-buy” rating to a “hold” rating in a research note on Monday, July 14th. Barrington Research reissued an “outperform” rating and set a $78.00 target price on shares of Henry Schein in a research note on Wednesday. Finally, Wall Street Zen lowered shares of Henry Schein from a “buy” rating to a “hold” rating in a research note on Saturday, October 11th. Five analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $76.67.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.